- Home
- ARQT vs KNTK Comparison
ARQT vs KNTK Comparison
Compare ARQT & KNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARQT | KNTK |
|---|---|---|
| Founded | 2016 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.0B |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ARQT | KNTK |
|---|---|---|
| Price | $24.19 | $47.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $34.00 | ★ $47.92 |
| AVG Volume (30 Days) | ★ 1.1M | 976.2K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 7.08% |
| EPS Growth | 88.79 | ★ 157.84 |
| EPS | N/A | ★ 2.63 |
| Revenue | ★ $376,072,000.00 | $160,617,000.00 |
| Revenue This Year | $34.46 | $7.52 |
| Revenue Next Year | $29.77 | $15.34 |
| P/E Ratio | ★ N/A | $17.36 |
| Revenue Growth | ★ 91.34 | 8.23 |
| 52 Week Low | $12.42 | $31.33 |
| 52 Week High | $31.77 | $49.55 |
Technical Indicators
Market Signals| Indicator | ARQT | KNTK |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 56.84 |
| Support Level | $22.56 | $39.80 |
| Resistance Level | $25.03 | $47.60 |
| Average True Range (ATR) | 0.96 | 1.55 |
| MACD | 0.35 | -0.24 |
| Stochastic Oscillator | 77.75 | 58.34 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About KNTK Kinetik Holdings Inc.
Kinetik Holdings Inc is a midstream operator that provides comprehensive gathering, transportation, compression, processing and treating services. Its activities also include NGL stabilization and transportation, produced water gathering and disposal, and crude oil gathering, stabilization, storage, and transportation. The company operates in two reportable segments: i) The Midstream Logistics segment operates under three service offerings: 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. ii) The Pipeline Transportation segment consists of two EMI Pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.